Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

被引:65
作者
Obaro, SK
Adegbola, RA
Chang, I
Banya, WAS
Jaffar, S
Mcadam, KWJP
Greenwood, BM
机构
[1] MRC Labs, Fajara, Senegal
[2] Wyeth Lederle Vaccines, W Henrietta, NY USA
[3] Wyeth Lederle Vaccines, Pearl River, NY USA
[4] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
关键词
safety; immunogenicity; pneumococcal conjugate vaccine;
D O I
10.1097/00006454-200005000-00014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Unrelenting high morbidity and mortality have mandated that immunogenic vaccines be used to combat pneumococcal disease in infants. Objectives. To evaluate the safety and immunogenicity of a nonavalent pneumococcal conjugate vaccine and the antigenic interaction when administered simultaneously with diphtheria, tetanus and pertussis vaccines. Methods. Two hundred seven infants were randomized to receive three doses of either nonavalent protein conjugate pneumococcal vaccine (PnCV) or inactivated polio vaccine (IPV) at 2, 3 and 4 months of age with routine Expanded Program of Immunization vaccines as scheduled. Vaccinees were visited on Days 1, 2 and 7 to observe local and systemic adverse reactions. Blood was drawn before the first dose and 1 month after the third dose. Antibody concentrations in sera were measured by standardized enzyme linked immunosorbent assay. Nasopharyngeal carriage of pneumococci was tested at 5 and 9 months of age. Results. No serious reactions were observed. Local induration and tenderness were observed more commonly at the site of administration of diphtheria, tetanus and pertussis vaccines than at the site of administration of IPV or PnCV. Between 79 and 91% achieved greater than or equal to 1 mu g/ml antibody against specific pneumococcal serotypes. Antibody responses to diphtheria and pertussis antigens were similar in both groups; however, antibody response to tetanus toroid was significantly lower in infants who received PnCV (geometric mean concentration, 11.1 vs. 17.4; P < 0.001). Nasopharyngeal carriage in PnCV-vaccinated children was reduced but not significantly different from those vaccinated with IPV. Conclusion. Simultaneous administration of PnCV with Expanded Program of Immunization vaccines is safe and immunogenic. Immune response to the composite antigens is likely to confer protection.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 18 条
[1]   Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants [J].
Ahman, H ;
Kayhty, H ;
Tamminen, P ;
Vuorela, A ;
Malinoski, F ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (02) :134-139
[2]   SERUM ANTIBODIES TO PNEUMOCOCCAL-C POLYSACCHARIDE IN CHILDREN - RESPONSE TO ACUTE PNEUMOCOCCAL OTITIS-MEDIA OR TO VACCINATION [J].
KOSKELA, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (06) :519-526
[3]   SIMPLE LATEX AGGLUTINATION METHOD FOR TYPING PNEUMOCOCCI [J].
LAFONG, AC ;
CROTHERS, E .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (02) :230-231
[4]   Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants [J].
Leach, A ;
Ceesay, SJ ;
Banya, WAS ;
Greenwood, BM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (04) :333-339
[5]  
LLOYDEVANS N, 1996, PEDIATR INFECT DIS J, V8, P66
[6]  
MANCLARK CR, 1986, MANUAL CLIN LABORATO, P388
[7]   Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine [J].
Mbelle, N ;
Heubner, RE ;
Wasas, AD ;
Kimura, A ;
Chang, I ;
Klugman, KP .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :1171-1176
[8]   A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children [J].
Obaro, SK ;
Huo, ZM ;
Banya, WAS ;
Henderson, MC ;
Monteil, MA ;
Leach, A ;
Greenwood, BM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (12) :1135-1140
[9]   Carriage of pneumococci after pneumococcal vaccination [J].
Obaro, SK ;
Adegbola, RA ;
Banya, WAS ;
Greenwood, BM .
LANCET, 1996, 348 (9022) :271-272
[10]  
PARADISO PR, 1993, PEDIATRICS, V92, P827